510(k) K811721
K811721 is an FDA 510(k) premarket notification submitted by Immulok, Inc. for the device "H-101 KAPPA,H-102 LAMBDA,H-107 LYSOZME". The FDA issued a decision of Substantially Equivalent on July 16, 1981. The device falls under product code DFH (Kappa, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5550. Immulok, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 16, 1981
- Date Received
- June 18, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Kappa, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5550
- Review Panel
- IM
- Submission Type